Skip to main content
Premium Trial:

Request an Annual Quote

Olink Inks Finland Distribution Pact

NEW YORK (GenomeWeb news) – Olink Bioscience said today that it has signed up Immuno Diagnostic to distribute its in situ protein detection systems in Finland.

Under the agreement, the Finnish company Immuno Diagnostic will distribute the Duolink in situ PLA product line, which is a proximity ligation assay technology that is used to detect proteins and their interactions and modifications. The technology allows for detection of target proteins with single-molecule resolution, Uppsala, Sweden-based Olink said.

"We see a great potential market for the PLA technology in the areas of academic and industrial research in Finland," Immuno Diagnostic's Sales Director and VP, Marko Laine, said in a statement.

Financial terms of the agreement were not released.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.